Nociceptin/Orphanin FQ Opioid Peptide-Receptor Expression in the Endometriosis-Associated Nerve Fibers—Possible Treatment Option?
Cells · 2023
DOI: 10.3390/cells12101395 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2023. Verfasst von Qihui Guan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Endometriosis Research Center, Department of Gynecology Charité with Center of Oncological Surgery, Charité, Campus Virchow-Klinikum, Augustenburger …. Hauptthemen laut MEDLINE: Endometriosis, Chronic Pain. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Grünenthal GmbH.
Abstract (Originalsprache)
Endometriosis (EM) is a chronic inflammatory disease affecting millions of women worldwide. Chronic pelvic pain is one of the main problems of this condition, leading to quality-of-life impairment. Currently, available treatment options are not able to treat these women accurately. A better understanding of the pain mechanisms would be beneficial to integrate additional therapeutic management strategies, especially specific analgesic options. To understand pain in more detail, nociceptin/orphanin FQ peptide (NOP) receptor expression was analyzed in EM-associated nerve fibers (NFs) for the first time. Laparoscopically excised peritoneal samples from 94 symptomatic women (73 with EM and 21 controls) were immunohistochemically stained for NOP, protein gene product 9.5 (PGP9.5), substance P (SP), calcitonin gene-related peptide (CGRP), tyrosine hydroxylase (TH), and vasoactive intestinal peptide (VIP). Peritoneal NFs of EM patients and healthy controls were positive for NOP and often colocalized with SP-, CGRP-, TH-, and VIP-positive nerve fibers, suggesting that NOP is expressed in sensory and autonomic nerve fibers. In addition, NOP expression was increased in EM associate NF. Our findings highlight the potential of NOP agonists, particularly in chronic EM-associated pain syndromes and deserve further study, as the efficacy of NOP-selective agonists in clinical trials.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Endometriosis Research Center, Department of Gynecology Charité with Center of Oncological Surgery, Charité, Campus Virchow-Klinikum, Augustenburger Platz 1, 13353 Berlin, Germany.
ORCID-Profile: Renata Voltolini Velho, Jalid Sehouli
Förderung
- Grünenthal GmbH
Zitieren
APA
Guan, Q., Velho, R. V., Jordan, A., Pommer, S., Radde, I., Sehouli, J., & Mechsner, S. (2023). Nociceptin/Orphanin FQ Opioid Peptide-Receptor Expression in the Endometriosis-Associated Nerve Fibers—Possible Treatment Option?. Cells. https://doi.org/10.3390/cells12101395
Vancouver
Guan Q, Velho RV, Jordan A, Pommer S, Radde I, Sehouli J, et al. Nociceptin/Orphanin FQ Opioid Peptide-Receptor Expression in the Endometriosis-Associated Nerve Fibers—Possible Treatment Option?. Cells. 2023. doi:10.3390/cells12101395
BibTeX
@article{Guan2023,
author = {Guan, Qihui and Velho, Renata Voltolini and Jordan, Alice and Pommer, Sabrina and Radde, Irene and Sehouli, Jalid and Mechsner, Sylvia},
title = {Nociceptin/Orphanin FQ Opioid Peptide-Receptor Expression in the Endometriosis-Associated Nerve Fibers—Possible Treatment Option?},
journal = {Cells},
year = {2023},
doi = {10.3390/cells12101395}
}
EUVIMED